Welcome to our Scientific Newsletter ??
Our next Antibody Analytics x SelectScience webinar will be on Tuesday 28th of May! Don’t miss our Senior Study Manager Dr. Gavin Meehan present the different in vitro assays we use for immuno-oncology drug discovery, as well as the new assays in development.
In other news, we’re delighted to share our newest Strategic Partner, ScreenIn3D. A University of Strathclyde spin-out, they specialise in lab-on-a-chip technology combined with 3D disease models. The partnership will allow us to develop models that more accurately recreate in vivo conditions, providing translational data like never before.
We’re currently attending three events this week, Swiss Biotech Day, Immuno 2024 and the I-O Summit Europe in London. Are you in London this week? Book a meeting with us to chat all things immunology.
Scientific Updates & Resources
What do you know about FcRn? ??
Initially known for its role in transporting Immunoglobulin-G (IgG) in passive immunity, the Neonatal Fc Receptor (FcRn) has emerged as a key player in regulating IgG serum levels. Harnessing this process has therapeutic potential for conditions like autoimmunity. Our Director of Biophysics, Dr. Nichole Cerutti, shares her latest insights. Read our scientific blog!
See us at upcoming events & conferences
Biotech and Beers networking event ??
Join our CSO, Scientific Director and BD Analyst for Biotech and Beers at the Babraham Research Campus! We’ll be chatting all things biotech at The George Inn on Thursday the 9th of May. Learn more and RSVP. Cheers!?
This?year we’re attending more than 13 conferences! ??
Catch us at these events:
If you would like to meet in person, you can pre-book a meeting with us.
Share your thoughts and leave us feedback! ??
How did you like our first issue? What would you like to see in the future? Please email us your thoughts and suggestions to: [email protected].
Best wishes,
The Antibody Analytics Team.